Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 9, 2022
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
Tue, March 8, 2022
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
Yanan Zhu Maintained (BLUE) at Hold with Decreased Target to $8 on, Mar 8th, 2022
Yanan Zhu of Wells Fargo, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $12 to $8 on, Mar 8th, 2022.
Yanan has made no other calls on BLUE in the last 4 months.
There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 1 agrees with Yanan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $10 on, Monday, March 7th, 2022
These are the ratings of the 3 analyists that currently disagree with Yanan
- Gena Wang of "Barclays" Downgraded from Hold to Sell and Decreased Target to $4 on, Monday, March 7th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $5 on, Monday, March 7th, 2022
- Salveen Richter of "Goldman Sachs" Downgraded from Hold to Strong Sell and Decreased Target to $10 on, Monday, November 8th, 2021
